Back to resultsCan Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder?
Primary Purpose
Agoraphobia, Social Phobia, PTSD
Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Thought Field Therapy (TFT)
Sponsored by
About this trial
This is an interventional treatment trial for Agoraphobia focused on measuring Anxiety disorder, Thought Field Therapy, Psychotherapy, Agoraphobia, Social Phobia, Post Traumatic Stress Disorder
Eligibility Criteria
Inclusion Criteria: One or more of the study diagnoses agoraphobia, social phobia and/or PTSD Exclusion Criteria: Ongoing psychosis Ongoing serious drug problems
Sites / Locations
- Sorlandet Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Thought Field Therapy (TFT)
Wait list control
Arm Description
Treatment with TFT, first one hour, then 1/2 hour.
Outcomes
Primary Outcome Measures
Global symptom index (gsi) on the Symptom checklist 90 revised (SCL-90-R)
Secondary Outcome Measures
Davidson Trauma Scale
Liebowitz Social Anxiety Scale
Hospital Anxiety and Depression Scale (HADS)
Fear Questionnaire (FQ)
Sheehan Disability Scale
Full Information
NCT ID
NCT00202709
First Posted
September 12, 2005
Last Updated
July 27, 2011
Sponsor
Sorlandet Hospital HF
1. Study Identification
Unique Protocol Identification Number
NCT00202709
Brief Title
Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder?
Official Title
Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder, a Prospective, Randomized Pilot Study With Wait List as Control Group.
Study Type
Interventional
2. Study Status
Record Verification Date
September 2005
Overall Recruitment Status
Completed
Study Start Date
May 2002 (undefined)
Primary Completion Date
August 2003 (Actual)
Study Completion Date
August 2003 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Sorlandet Hospital HF
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to find out if Thought Field Therapy has effect on certain anxiety disorders; agoraphobia, social phobia, and post traumatic stress disorder (PTSD).
Detailed Description
Thought Field Therapy is an alternative treatment method that has been shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 52 patients, with one or more of the diagnoses agoraphobia, social phobia and/or PTSD, where randomized to either treatment with TFT or a wait list. The treatment group all got treatment in one week. 2 1/2 months later both the treatment group and the control group were tested on the same items as before the treatment started. After this evaluation phase the control group got the same treatment as the treatment or study group. Both groups were evaluated 3 and 12 months after treatment, the study group also 6 months after treatment. 4 patients were omitted because they changed groups. The study were performed from May 2002 until June 2003.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Agoraphobia, Social Phobia, PTSD
Keywords
Anxiety disorder, Thought Field Therapy, Psychotherapy, Agoraphobia, Social Phobia, Post Traumatic Stress Disorder
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
52 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Thought Field Therapy (TFT)
Arm Type
Experimental
Arm Description
Treatment with TFT, first one hour, then 1/2 hour.
Arm Title
Wait list control
Arm Type
No Intervention
Intervention Type
Behavioral
Intervention Name(s)
Thought Field Therapy (TFT)
Other Intervention Name(s)
Wait list control
Intervention Description
Treatment with TFT twice in one week
Primary Outcome Measure Information:
Title
Global symptom index (gsi) on the Symptom checklist 90 revised (SCL-90-R)
Time Frame
Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.
Secondary Outcome Measure Information:
Title
Davidson Trauma Scale
Time Frame
Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.
Title
Liebowitz Social Anxiety Scale
Time Frame
Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.
Title
Hospital Anxiety and Depression Scale (HADS)
Time Frame
Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.
Title
Fear Questionnaire (FQ)
Time Frame
Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.
Title
Sheehan Disability Scale
Time Frame
Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
One or more of the study diagnoses agoraphobia, social phobia and/or PTSD
Exclusion Criteria:
Ongoing psychosis
Ongoing serious drug problems
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Audun C Irgens, MD
Organizational Affiliation
Sorlandet Hospital HF
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sorlandet Hospital
City
Arendal
ZIP/Postal Code
4809
Country
Norway
12. IPD Sharing Statement
Citations:
PubMed Identifier
23141789
Citation
Irgens A, Dammen T, Nysaeter TE, Hoffart A. Thought Field Therapy (TFT) as a treatment for anxiety symptoms: a randomized controlled trial. Explore (NY). 2012 Nov-Dec;8(6):331-8. doi: 10.1016/j.explore.2012.08.002.
Results Reference
derived
Learn more about this trial
Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder?
We'll reach out to this number within 24 hrs